Dr George Fareed Interview – Part 2

In the second part of our interview with the esteemed Dr George Fareed, MD, we cover a range of critical questions regarding the treatment of COVID-19.

  • Dr Fareed’s ability to get early treatment to his patients, given the context of restrictions by many medical and pharmacy boards, and by several major pharmacy chains
  • his results with the early treatment of some 300 patients
  • early treatment as a means to avoid long-term effects, to avoid for the patient to become a long-hauler
  • how Dr Fareed treated residents of a nursing home, following a major, rapid, outbreak; what was the result of the intervention; how did the families support the treatment
  • the recommendations of Dr Fareed for those managing nursing homes, in terms of prophylaxis and early treatment
  • how staff was protected and treated early in case of an infection
  • the emergence of Ivermectin-based treatments, as an alternative option to Hydroxychloroquine-based therapies, for the early treatment of COVID-19
  • what kind of prophylaxis does Dr Fareed, who has been extensively exposed to the virus, take for himself
  • the tragedy of early treatment not to being recognized, or being out rightly opposed, by the authorities in the US

See first part at: